• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Merial, Boehringer Ingelheim Vetmedica seal deal

February 1, 2003

Orlando-Merial and Boehringer Ingelheim Vetmedica Inc. (BI) have just inked a deal on a long-term strategic alliance.

Orlando-Merial and Boehringer Ingelheim Vetmedica Inc. (BI) have just inked a deal on a long-term strategic alliance.

At presstime, the companies announced certain details of the joint agreementat the recently concluded North American Veterinary Conference here.

Tom Zerzan, vice president of Merial's companion animal business in NorthAmerica, tells DVM Newsmagazine, the deal itself was about one year in themaking. "Today marks another milestone in Merial's history. The commercializationagreement with Boehringer Ingelheim Vetmedica demonstrates our continuedcommitment to seek newer and innovative ways to expand our services andproduct portfolio for veterinarians.

The deal gives Merial exclusive rights to sell new Boehringer IngelheimVetmedica products for companion animals. The first companion animal productsare anticipated sometime in 2003.

While the company would not offer details of new product introductions,the industry buzz is that the product will be in the category of pain management.

Advertisement

In short, the deal will likely give Merial entry into the lucrative painmanagement segment, pending Food and Drug Administration approval, and itgives Boehringer Ingelheim Vetmedica the sales and marketing muscle to bringa major new introduction into the veterinary market.

George Heidgerken, president and COO of Boehringer Ingelheim Vetmedica,says "We see this close cooperation as a perfect match for our twocompanies. Boehringer Ingelheim Vetmedica has successfully established adifferentiated pet line in Europe. This will now be launched in the U.S.with Merial as a highly competent partner. With their sales and marketingclout, as well as their depth of technical support, Merial is the leaderin bringing innovative products to the market."

Zerzan says that the agreement between the two companies will ultimatelyraise the level of care for companion animals, and remains the top strategicgoal for the company.

While eyes are on the pain management product, Zerzan adds that the agreementwill include additional companion animal products.

Related Content:

Breaking News
Veterinarian kills 2 police officers in Mississippi
Veterinarian kills 2 police officers in Mississippi
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals

Advertisement

Latest News

Managing wounds in pet patients

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

View More Latest News
Advertisement